Nabi Biopharmaceuticals (NABI) Reports Q4 Loss of $0.05
Tweet
Share
E-mailGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Financial Fact:
General and administrative expenses: 2.2M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
General and administrative expenses: 2.2M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q4 EPS of ($0.05), versus ($0.08) reported last year.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Equity Bancshares to acquire Iowa's Lincoln Bancorp for $123.8M
- Lakeland wins second foul weather gear contract with Hong Kong air service
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
